Physician profile
Subrata Kar
NPI 1821262742
$2,356.41
in general payments reported to CMS, 2019-2025
16 companies · $313 in 2025
The $313 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $535 · 2020: $282 · 2021: $55.96 · 2022: $622 · 2023: $305 · 2024: $244 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $861.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $627.06 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $604.27 | 2020-2025 | |
| Abiomed | $324.57 | 2019-2025 | |
| Medtronic Vascular, INC. | $266.01 | 2019-2020 | |
| Shockwave Medical, INC | $93.30 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $91.97 | 2021-2025 | Symplicity G3, Linq II |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $76.25 | 2020 | |
| Philips North America LLC | $60.46 | 2023 | |
| Janssen Pharmaceuticals, INC | $45.59 | 2021-2023 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $41.71 | 2023 | Inpefa |
| E.R. Squibb & Sons, L.L.C. | $26.26 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $23.56 | 2020 | |
| Alnylam Pharmaceuticals INC. | $20.99 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.40 | 2022 | |
| Merck Sharp & Dohme LLC | $19.08 | 2023 | Verquvo |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $14.93 | 2023 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Subrata Kar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.